Tools
Tools
Heeschen, C., Lehmann, R., Honold, J., Assmus, B., Aicher, A., Walter, D.H., Martin, H., Zeiher, A.M. and Dimmeler, S., 2004. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation, 109 (13), pp. 1615-1622. ISSN 0009-7322
|
Text
197522_1980 Aicher Publisher.pdf Download (358kB) | Preview |
Abstract
Background— Cell therapy with bone marrow–derived stem/progenitor cells is a novel option for improving neovascularization and cardiac function in ischemic heart disease. Circulating endothelial progenitor cells in patients with coronary heart disease are impaired with respect to number and functional activity. However, whether this impairment also extends to bone marrow–derived mononuclear cells (BM-MNCs) in patients with chronic ischemic cardiomyopathy (ICMP) is unclear
| Item Type: | Journal article | ||||
|---|---|---|---|---|---|
| Publication Title: | Circulation | ||||
| Creators: | Heeschen, C., Lehmann, R., Honold, J., Assmus, B., Aicher, A., Walter, D.H., Martin, H., Zeiher, A.M. and Dimmeler, S. | ||||
| Publisher: | American Heart Association | ||||
| Place of Publication: | Dallas, Texas, USA | ||||
| Date: | 2004 | ||||
| Volume: | 109 | ||||
| Number: | 13 | ||||
| ISSN: | 0009-7322 | ||||
| Identifiers: |
|
||||
| Rights: | Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited | ||||
| Divisions: | Schools > School of Science and Technology | ||||
| Record created by: | EPrints Services | ||||
| Date Added: | 09 Oct 2015 10:09 | ||||
| Last Modified: | 08 Feb 2024 11:18 | ||||
| URI: | https://irep.ntu.ac.uk/id/eprint/8581 |
Actions (login required)
 |
Edit View |
Views
Views per month over past year
Downloads
Downloads per month over past year
